Gordon Sussman Clinical Research, Inc.

Toronto, Ontario M4V1R2

0 studies enrolling now · 12 studies all time

What they study most

Agammaglobulinemia, Allergic Rhinitis Due to Cat Allergy, Antibody Deficiency, Food Allergy, Hereditary Angioedema, Hereditary Angioedema (HAE), Hypogammaglobulinemia, Immunologic Deficiency Syndrome, Peanut Allergy, Primary Immunodeficiency

Studies at this site

• Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy — Completed
• Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy — Completed
• A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat — Stopped early
• CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks — Completed
• PALISADE Follow-on Study (ARC004) — Completed
• Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) — Completed
• Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• Safety Study of Viaskin Peanut to Treat Peanut Allergy — Completed
• Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children — Status unconfirmed
• Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency — Completed